XPH vs. XLVI
XPH (SPDR S&P Pharmaceuticals ETF) and XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) are both exchange-traded funds - XPH is a Health & Biotech Equities fund tracking the S&P Pharmaceuticals Select Industry Index, while XLVI is a Derivative Income fund actively managed by State Street. XPH is passively managed, while XLVI is actively managed. A 0.54 correlation means they provide meaningful diversification when combined. Both charge a 0.35% expense ratio.
Performance
XPH vs. XLVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XPH achieves a 0.66% return, which is significantly higher than XLVI's -0.67% return.
XPH
- 1D
- 1.10%
- 1M
- -4.74%
- YTD
- 0.66%
- 6M
- 4.44%
- 1Y
- 37.98%
- 3Y*
- 13.07%
- 5Y*
- 3.50%
- 10Y*
- 3.44%
XLVI
- 1D
- 0.67%
- 1M
- 2.30%
- YTD
- -0.67%
- 6M
- 0.76%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XPH vs. XLVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 33.73% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | -0.67% | 12.79% |
Correlation
The correlation between XPH and XLVI is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jul 31, 2025 | 0.54 |
XPH vs. XLVI - Sectors Allocation Comparison
Sectors
XPH
XLVI
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
XPH
XLVI
-
Basic Materials
XPH
-
XLVI
-
Communication Services
XPH
-
XLVI
-
Consumer Cyclical
XPH
-
XLVI
-
Consumer Defensive
XPH
-
XLVI
-
Energy
XPH
-
XLVI
-
Financial Services
XPH
-
XLVI
Industrials
XPH
-
XLVI
-
Real Estate
XPH
-
XLVI
-
Technology
XPH
-
XLVI
-
Utilities
XPH
-
XLVI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XPH vs. XLVI — Risk / Return Rank
XPH
XLVI
XPH vs. XLVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XPH | XLVI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.77 | — | — |
Sortino ratioReturn per unit of downside risk | 2.51 | — | — |
Omega ratioGain probability vs. loss probability | 1.30 | — | — |
Calmar ratioReturn relative to maximum drawdown | 3.19 | — | — |
Martin ratioReturn relative to average drawdown | 11.37 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XPH | XLVI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.77 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.17 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.16 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 1.33 | -0.94 |
Drawdowns
XPH vs. XLVI - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for XPH and XLVI.
Loading charts...
Drawdown Indicators
| XPH | XLVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.03% | -8.14% | -39.89% |
Max Drawdown (1Y)Largest decline over 1 year | -11.97% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -23.57% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -31.63% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | — | — |
Current DrawdownCurrent decline from peak | -7.22% | -4.02% | -3.20% |
Average DrawdownAverage peak-to-trough decline | -17.25% | -1.95% | -15.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.35% | — | — |
Volatility
XPH vs. XLVI - Volatility Comparison
Loading charts...
Volatility by Period
| XPH | XLVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.03% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 16.77% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 21.52% | 10.94% | +10.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.84% | 10.94% | +9.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.10% | 10.94% | +11.16% |
XPH vs. XLVI - Expense Ratio Comparison
Both XPH and XLVI have an expense ratio of 0.35%.
Dividends
XPH vs. XLVI - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 0.66%, less than XLVI's 11.53% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 11.53% | 5.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
XPH and XLVI have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
XPH and XLVI have the same expense ratio: 0.35% per year.
XLVI has the higher dividend yield at 11.53%, compared with 0.66% for XPH.
XPH is categorized as Health & Biotech Equities, while XLVI is Derivative Income.
Find the right allocation for XPH and XLVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer